Immuno Oncology Assays Market - 2025-2033

July 2026 | 48 pages | ID: I5669ECE9F23EN
DataM Intelligence

Abstracts

Immuno Oncology Assays Marketis is growing with a CAGR of 12.80% during the forecast period 2026-2035.

The Immuno Oncology Assays Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.

A Immuno Oncology Assays Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.

Not Listed in TOC

Regional Analysis for Immuno Oncology Assays Market:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

This Report Covers:

• Go-to-market Strategy.
• Neutral perspective on the market performance.
• Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
• Customized regional/country reports as per request and country level analysis.
• Potential & niche segments and regions exhibiting promising growth covered.
• Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Research Process:

Both primary and secondary data sources have been used in the global Immuno Oncology Assays Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Contents

1. MARKET INTRODUCTION AND SCOPE

1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope

2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS

3. MARKET HIGHLIGHTS AND STRATEGIC TAKEAWAYS

3.1. Key Trends and Future Projections

4. SNIPPET BY TYPE

4.1. Snippet by Treatment
4.2. Snippet by Route of Administration
4.3. Snippet by Region

5. DYNAMICS

5.1. Impacting Factors
  5.1.1. Drivers
    5.1.1.1. Increasing Developments in Immuno-Oncology Sector
    5.1.1.2. Rising Prevalence of Cancer
  5.1.2. Restraints
    5.1.2.1. High Cost of Assays
    5.1.2.2. Competition from Alternative Cancer Screening Methods
    5.1.2.3. XX
  5.1.3. Opportunity
    5.1.3.1. Collaborations and Partnerships Among the Companies
    5.1.3.2. XX
  5.1.4. Impact Analysis

6. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK

6.1. Market Leaders and Pioneers
  6.1.1. Emerging Pioneers and Prominent Players
  6.1.2. Established Leaders with Largest Marketing Brand
  6.1.3. Market Leaders with Established Products
6.2. Latest Developments and Breakthroughs
6.3. Regulatory and Reimbursement Landscape
  6.3.1. North America
  6.3.2. Europe
  6.3.3. Asia Pacific
  6.3.4. Latin America
  6.3.5. Middle East & Africa
6.4. Porter’s Five Forces Analysis
6.5. Supply Chain Analysis
6.6. Patent Analysis
6.7. SWOT Analysis
6.8. Pipeline Analysis
6.9. Epidemiology Analysis
6.10. Unmet Needs and Gaps
6.11. Recommended Strategies for Market Entry and Expansion
6.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
6.13. Pricing Analysis and Price Dynamics
6.14. Key Opinion Leaders

7. IMMUNO-ONCOLOGY ASSAYS MARKET PRODUCT TYPE OUTLOOK

7.1. Introduction
  7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  7.1.2. Market Attractiveness Index, By Product Type
7.2. Instruments*
  7.2.1. Introduction
  7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Consumables
7.4. Software and Services

8. IMMUNO-ONCOLOGY ASSAYS MARKET ASSAY TYPE OUTLOOK

8.1. Introduction
  8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Assay Type
  8.1.2. Market Attractiveness Index, By Assay Type
8.2. Cell Proliferation Assays*
  8.2.1. Introduction
  8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Cell Migration and Invasion Assays
8.4. Phagocytosis Assays
8.5. Immune Cell Killing Assays
8.6. Others

9. IMMUNO-ONCOLOGY ASSAYS MARKET TECHNOLOGY OUTLOOK

9.1. Introduction
  9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  9.1.2. Market Attractiveness Index, By Technology
9.2. PCR*
  9.2.1. Introduction
  9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. NGS
9.4. Immunoassay
9.5. Flow Cytometry
9.6. Others

10. IMMUNO-ONCOLOGY ASSAYS MARKET INDICATION OUTLOOK

10.1. Introduction
  10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
  10.1.2. Market Attractiveness Index, By Indication
10.2. Colorectal Cancer*
  10.2.1. Introduction
  10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Breast Cancer
10.4. Lung Cancer
10.5. Melanoma
10.6. Others

11. IMMUNO-ONCOLOGY ASSAYS MARKET END USER OUTLOOK

11.1. Introduction
  11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  11.1.2. Market Attractiveness Index, By End User
11.2. Academic Institutes*
  11.2.1. Introduction
  11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Research Organizations
11.4. Diagnostics Centers
11.5. Others

12. IMMUNO-ONCOLOGY ASSAYS MARKET, BY REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES

13. INTRODUCTION

13.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  13.1.1. Market Attractiveness Index, By Region
13.2. North America
  13.2.1. Introduction
  13.2.2. Key Region-Specific Dynamics
  13.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  13.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Assay Type
  13.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  13.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
  13.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

14. MARKET SIZE ANALYSIS AND Y-O-Y GROWTH ANALYSIS (%), BY COUNTRY

14.1. U.S.
  14.1.1. Canada
    14.1.1.1. Mexico
14.2. Europe
  14.2.1. Introduction
  14.2.2. Key Region-Specific Dynamics
  14.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  14.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Assay Type
  14.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  14.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
  14.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  14.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    14.2.8.1. Germany
    14.2.8.2. UK
    14.2.8.3. France
    14.2.8.4. Spain
    14.2.8.5. Italy
    14.2.8.6. Rest of Europe
14.3. Asia-Pacific
  14.3.1. Introduction
  14.3.2. Key Region-Specific Dynamics
  14.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  14.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Assay Type
  14.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  14.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
  14.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  14.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    14.3.8.1. China
    14.3.8.2. India
    14.3.8.3. Japan
    14.3.8.4. South Korea
    14.3.8.5. Rest of Asia-Pacific
14.4. South America
  14.4.1. Introduction
  14.4.2. Key Region-Specific Dynamics
  14.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  14.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Assay Type
  14.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  14.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
  14.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  14.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    14.4.8.1. Brazil
    14.4.8.2. Argentina
    14.4.8.3. Rest of South America
14.5. Middle East and Africa
  14.5.1. Introduction
  14.5.2. Key Region-Specific Dynamics
  14.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  14.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Assay Type
  14.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  14.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
  14.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

15. COMPETITIVE LANDSCAPE AND MARKET POSITIONING

16. COMPETITIVE OVERVIEW AND KEY MARKET PLAYERS

16.1. Market Share Analysis and Positioning Matrix
16.2. Strategic Partnerships, Mergers & Acquisitions
16.3. Key Developments in Product Portfolios and Innovations
16.4. Company Benchmarking

17. COMPANY PROFILES

Key Players

1. MERCK KGAA*

1.1. Company Overview
  1.1.1. Product Portfolio
    1.1.1.1. Product Description
    1.1.1.2. Product Key Performance Indicators (KPIs)
    1.1.1.3. Historic and Forecasted Product Sales
    1.1.1.4. Product Sales Volume

2. FINANCIAL OVERVIEW

2.1. Company Revenue
  2.1.1. Geographical Revenue Shares
    2.1.1.1. Revenue Forecasts
  2.1.2. Key Developments
    2.1.2.1. Mergers & Acquisitions
    2.1.2.2. Key Product Development Activities
    2.1.2.3. Regulatory Approvals, etc.
  2.1.3. SWOT Analysis
2.2. Thermo Fisher Scientific Inc.
2.3. Lunaphore Technologies SA.
2.4. Eve Technologies.
2.5. Vivia Biotech S.L
2.6. Illumina, Inc.
2.7. Charles River Laboratories
2.8. Bio-Techne
2.9. Creative Biolabs
2.10. Miltenyi Biotec
2.11. Adipogen Life SciencesLIST NOT EXHAUSTIVE

3. ASSUMPTION AND RESEARCH METHODOLOGY

3.1. Data Collection Methods
3.2. Data Triangulation
3.3. Forecasting Techniques
3.4. Data Verification and Validation

4. APPENDIX

4.1. About Us and Services
4.2. Contact Us